Thiazolidinedione use in patients with Type 2 diabetes may increase risk for diabetic macular edema
Treatment with glucose-lowering thiazolidinedione drugs in patients with Type 2 diabetes appears to be associated with an increased risk of diabetic macular edema (a complication that may affect vision) at 1-year and 10-year ...
Jun 11, 2012
0
0